Roland A Newman

This inventor holds 30 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Monoclonal Antibodies. Top assignees: Idec Pharmaceuticals Corporation, Biogen Idec, Inc., Mitsubishi Tanabe Pharma Corporation. Active years: 1997-2024.

USPTO Granted Patents = 30 (Patent Applications = 2)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 4.3

ph-index = 19

Forward Citations = 2,618(Granted Patents)

Company Filing History:

17 out of 37

Idec Pharmaceuticals Corporation

Mitsubishi Tanabe Pharma Corporation

patents

4. 1 out of 3

Idec Pharmaceutical Corporation

patents

5. 1 out of 1

Mitsubishi Tanabe Pharma Corporat

patent

6. 1 out of 834,411

Other

patents

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Drug Conjugates

Monoclonal Antibodies

Autoimmune Diseases

Chimeric Antibodies

Therapeutic Applications

Human Therapy

Neutralizing Antibodies

CD20 Antigen

CD4 Antibodies

RSV Neutralization

B Cell Lymphoma

Binding Agents

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060427 - Drug conjugates of cMET monoclonal binding agents, and uses thereof (2024-08-13),

2. 11299547 - CMET monoclonal binding agents, drug conjugates thereof and uses thereof (2022-04-12),

3. 11242403 - Syndecan-1 (CD138) binding agents and uses thereof (2022-02-08),

4. 10323095 - Antibody-fynomer conjugates (2019-06-18),

5. 7744877 - Expression and use of anti-CD20 Antibodies (2010-06-29),

6. 7452534 - Recombinant anti-CD4 antibodies for human therapy (2008-11-18),

7. 7422739 - Anti-CD20 antibodies (2008-09-09),

8. 7381560 - Expression and use of anti-CD20 antibodies (2008-06-03),

9. 7338658 - Recombinant anti-CD4 antibodies for human therapy (2008-03-04),

10. 7122187 - Treating autoimmune diseases with humanized anti-CD40L antibody (2006-10-17),

11. 7074406 - Treating allergic diseases with humanized anti-CD40L antibody (2006-07-11),

12. 6682734 - Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma (2004-01-27),

13. 6506383 - Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies (2003-01-14),

14. 6440418 - Methods of treating autoimmune diseases with gp39-specific antibodies (2002-08-27),

15. 6399061 - Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma (2002-06-04),

Title: Roland A Newman - Pioneering Inventor from San Diego

Introduction: Roland A Newman is a distinguished inventor based in San Diego, California, known for his groundbreaking contributions to various fields.

Latest Patents: Roland A Newman holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over three decades, Roland A Newman has established himself as a visionary inventor with a keen focus on developing innovative solutions to complex problems. He has received numerous accolades for his work, including the prestigious Inventor of the Year award.

Collaborations: Throughout his career, Roland A Newman has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Roland A Newman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on various industries is truly remarkable, and his legacy as a pioneering inventor is set to endure for years to come.